CTI was founded in 2013 by former MEDTEC corporation executives, specializing in the Innovation driving peripheral vascular therapies.

CTI vascular provides the full spectrum of services to design, develop and deliver finished medical devices to market.

We offer a comprehensive product & technology portofolio for licensing and technology divestiture.

The CTI vascular management team comprises a group of seasoned industry professionals, many of whom have extensive experience in the world’s largest medical device companies. The collective experience of our management team provides a unique understanding of the strategic goals of our customers and ensures that CTI vascular is a partner who responds proactively to customer challenges and opportunities.

CTI has the capabilities to deliver innovative, cost-effective new products through a best-in-class team with the experience to meet large corporation’s quality needs.

Expanding the horizon of peripheral vascular therapies
No.1 in creation of novel & cost effective technology
We become our customers most valued business partner

Commitment to Innovation

«CTI Vascular is committed to innovation and focuses on delivering novel medical devices based on a close partnership with leading physicians to offer customers & patients worldwide safe and cost-effective solutions»